Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Doximity (DOCS) over the last 5 years, with Q4 2025 value amounting to $177.7 million.

  • Doximity's Total Liabilities rose 2601.52% to $177.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $177.7 million, marking a year-over-year increase of 2601.52%. This contributed to the annual value of $181.7 million for FY2025, which is 208.29% up from last year.
  • As of Q4 2025, Doximity's Total Liabilities stood at $177.7 million, which was up 2601.52% from $161.6 million recorded in Q3 2025.
  • Over the past 5 years, Doximity's Total Liabilities peaked at $181.7 million during Q1 2025, and registered a low of $93.3 million during Q4 2021.
  • Its 5-year average for Total Liabilities is $145.1 million, with a median of $151.7 million in 2022.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 5448.47% in 2022, then tumbled by 174.78% in 2024.
  • Doximity's Total Liabilities (Quarter) stood at $93.3 million in 2021, then surged by 46.71% to $136.9 million in 2022, then fell by 0.64% to $136.0 million in 2023, then grew by 3.68% to $141.0 million in 2024, then grew by 26.02% to $177.7 million in 2025.
  • Its Total Liabilities was $177.7 million in Q4 2025, compared to $161.6 million in Q3 2025 and $178.9 million in Q2 2025.